Total Funding
43
Total FundingSeries A raised
Growth Score in past quarter
pts
Heat Score 43 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Demetrix is a biotechnology company that researches and produces bioactive ingredients.
William Haseltine: Co FounderPast Role: Human Genome Sciences, Chairman & CEO
Jay Keasling: Co-founder
About the Company
Demetrix uses fermentation technology to produce rare cannabinoids for the health and wellness industries. The company identifies rare bioactive compounds and, through rigorous research, develops those with the greatest potential for human health and well-being. Their methods mimic nature’s chemistry, and we produce bioactive efficiently and
affordably, maintaining a light environmental footprint.
Demetrix is based in Berkeley, CA, with offices in Raleigh, NC.